Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: A systematic review

Trials

Volumn 18, Issue 1, 2017, Pages

  Althunian, Turki A ^a   de Boer, Anthonius ^a   Klungel, Olaf H ^a,b   Insani, Widya N ^a   Groenwold, Rolf H H ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Drug regulation; Methodology; Non inferiority margin; Non inferiority trials

Indexed keywords

CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DOUBLE BLIND PROCEDURE; EDITOR; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOGLINEAR MODEL; MEDLINE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; EQUIVALENCE TRIAL (TOPIC); METHODOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; EQUIVALENCE TRIALS AS TOPIC; HUMANS; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 85014701687     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-017-1859-x     Document Type: Review

References (25)

1. Suda KJ, Hurley AM, McKibbin T, Motl Moroney SE. Publication of noninferiority clinical trials: changes over a 20-year interval. Pharmacotherapy. 2011;31(9):833-9.
2. Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER). Guidance for Industry Non-Inferiority Clinical Trials. Food and Drug Administration, U.S. Department of Health and Human Services. 2010. http://www.fda.gov/downloads/Drugs/./Guidances/UCM202140.pdf. Accessed 15 Oct 2014.
3. Mulla SM, Scott IA, Jackevicius CA, You JJ, Guyatt GH. How to use a noninferiority trial: users' guides to the medical literature. JAMA. 2012;308(24):2605-11.
4. Kaji AH, Lewis RJ. Noninferiority trials: is a new treatment almost as effective as another? JAMA. 2015;313(23):2371-2.
5. ICH Expert Working Group. ICH Harmonised Tripartite Guideline: statistical principles for clinical trials (E9). ICH. 1998. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf. Accessed 15 Oct 2014.
6. ICH Expert Working Group. ICH Harmonised Tripartite Guideline: choice of control group in clinical trials (E 10). ICH. 2000. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E10/Step4/E10_Guideline.pdf. Accessed 15 Oct 2014.
7. Committee for Medicinal Products for Human Use. Guideline on the choice of the non-inferiority margin. European Medicines Agency. 2005. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003636.pdf. Accessed 15 Oct 2014.
8. Le Henanff A, Giraudeau B, Baron G, Ravaud P. Quality of reporting of noninferiority and equivalence randomized trials. JAMA. 2006;295(10):1147-51.
9. Wangge G, Klungel OH, Roes KC, de Boer A, Hoes AW, Knol MJ. Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review. PLoS One. 2010;5(10):e13550. doi: 10.1371/journal.pone.0013550.
10. Schiller P, Burchardi N, Niestroj M, Kieser M. Quality of reporting of clinical non-inferiority and equivalence randomised trials--update and extension. Trials. 2012;13:214. doi: 10.1186/1745-6215-13-214.
11. Hernandez AV, Pasupuleti V, Deshpande A, Thota P, Collins JA, Vidal JE. Deficient reporting and interpretation of non-inferiority randomized clinical trials in HIV patients: a systematic review. PLoS One. 2013;8(5):e63272. doi: 10.1371/journal.pone.0063272.
12. Donken R, de Melker HE, Rots NY, Berbers G, Knol MJ. Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials. Vaccine. 2015;33(12):1426-32.
13. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ, CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006;295(10):1152-60.
14. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594-604.
15. Rothmann M, Li N, Chen G, Chi GY, Temple R, Tsou HH. Design and analysis of non-inferiority mortality trials in oncology. Stat Med. 2003;22(2):239-64.
16. Rothmann MD, Wiens BL, Chan IS. Design and analysis of non-inferiority trials. Boca Raton: Chapman & Hall/CRC; 2012.
17. Kaul S, Diamond GA. Good enough: A primer on the analysis and interpretation of noninferiority trials. Ann Intern Med. 2006;145(1):62-9.
18. Snapinn S, Jiang Q. Preservation of effect and the regulatory approval of new treatments on the basis of non-inferiority trials. Stat Med. 2008;27(3):382-91. doi: 10.1002/sim.3073.
19. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
20. International Committee of Medical Journal Editors (ICMJE). Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. ICMJE. 2015. http://www.icmje.org/icmje-recommendations.pdf. Accessed on 5 Nov 2015.
21. Thomson Reuters. InCites™Journal Citation Reports ®. Web of Science. 2015 https://jcr.incites.thomsonreuters.com/JCRJournalHomeAction.action. Accessed 11 Oct 2015.
22. Lange S, Freitag G. Choice of delta: requirements and reality--results of a systematic review. Biom J. 2005;47(1):12-27. discussion 99-107.
23. Parienti JJ, Verdon R, Massari V. Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance. BMC Med Res Methodol. 2006;6:46.
24. Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev. 2012;11:MR000030. doi: 10.1002/14651858.MR000030.pub2.
25. Wangge G, Putzeist M, Knol MJ, et al. Regulatory scientific advice on non-inferiority drug trials. PLoS One. 2013;8(9):e74818. doi: 10.1371/journal.pone.0074818.